Literature DB >> 6229340

Feedback suppression of the immune response in vivo. III. Lyt-1+ B cells are suppressor-inducer cells.

T Shimamura, S Habu, K Hashimoto, S Sasaki.   

Abstract

We previously demonstrated that injection of a high dose (4 X 10(9] of sheep erythrocytes (SRBC) into C57BL/6 mice results in the generation of splenic B cells (plastic nonadherent, Thy-1- and Ig+) which, when transferred to normal syngeneic recipients, subsequently induce antigen-specific suppressor T cells to suppress the recipient's plaque-forming cell (PFC) responses to SRBC. In the present study we characterized the suppressor-inducer B cells phenotypically. Cytotoxic treatment of the donor's immune spleen cells with anti-Lyt-1 antibody plus complement (C'), but not with anti-Lyt-2 antibody plus C', relieved the suppression of PFC responses in recipients. The FcRr+ population separated by EA-rosette formation showed enriched suppressor-inducing activity, whereas the FcRr- population showed no activity. Our findings, taken together with the previous ones, suggest that suppressor-inducer cells are Thy-1-, Lyt-1+, Lyt-2-, FcRr+, and Ig+.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6229340     DOI: 10.1016/0008-8749(84)90242-9

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  9 in total

Review 1.  Regulatory B cells in autoimmunity: developments and controversies.

Authors:  Claudia Mauri; Paul A Blair
Journal:  Nat Rev Rheumatol       Date:  2010-09-21       Impact factor: 20.543

Review 2.  Multiple mechanisms of immune suppression by B lymphocytes.

Authors:  Matthew W Klinker; Steven K Lundy
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

Review 3.  Reprogramming of B cells into regulatory cells with engineered fusokines.

Authors:  Jiusheng Deng; Jacques Galipeau
Journal:  Infect Disord Drug Targets       Date:  2012-06

4.  Augmentation of delayed-type hypersensitivity to high dose sheep erythrocytes by cyclosporin A in the mouse: influence of drug dosage and route of administration and analysis of spleen cell populations.

Authors:  L M Webster; A W Thomson
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

Review 5.  Experimental models of B cell tolerance in transplantation.

Authors:  Michelle L Cowan; Roger Sciammas; Anita S Chong
Journal:  Semin Immunol       Date:  2011-09-16       Impact factor: 11.130

Review 6.  Matchmaking the B-cell signature of tolerance to regulatory B cells.

Authors:  A S Chong; R Sciammas
Journal:  Am J Transplant       Date:  2011-10-03       Impact factor: 8.086

Review 7.  B cell regulation in cancer and anti-tumor immunity.

Authors:  Anushruti Sarvaria; J Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2017-06-19       Impact factor: 11.530

8.  B Cells with Regulatory Function in Animal Models of Autoimmune and Non-Autoimmune Diseases.

Authors:  Mei Lin; Zuomin Wang; Xiaozhe Han
Journal:  Open J Immunol       Date:  2015-03

Review 9.  Phenotypes, Functions, and Clinical Relevance of Regulatory B Cells in Cancer.

Authors:  Jin Shang; Haoran Zha; Yufa Sun
Journal:  Front Immunol       Date:  2020-10-22       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.